Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | EC17 |
| Synonyms | |
| Therapy Description |
EC17 (Folate-FITC ) is composed of folate conjugated to fluorescein isothiocyanate, which binds to folate receptors and induces an immune response towards folate receptor-expressing cells (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| EC17 | Folate-FITC|EC-17 | FOLR1-targeted Therapy 24 | EC17 (Folate-FITC ) is composed of folate conjugated to fluorescein isothiocyanate, which binds to folate receptors and induces an immune response towards folate receptor-expressing cells (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|